Subconjunctival bevacizumab for corneal neovascularization

被引：0
|
作者：
Mesut Erdurmus
Yuksel Totan
机构：
[1] Fatih University Medical School,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Bevacizumab; Corneal neovascularization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1577 / 1579
页数：2
相关论文
共 50 条
  • [1] Subconjunctival bevacizumab for corneal neovascularization
    Doctor, Priyanka P.
    Bhat, Pooja V.
    Foster, C. Stephen
    CORNEA, 2008, 27 (09) : 992 - 995
  • [2] Subconjunctival bevacizumab for corneal neovascularization
    Erdurmus, Mesut
    Totan, Yuksel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) : 1577 - 1579
  • [3] Subconjunctival bevacizumab for corneal neovascularization
    Gueudry, J.
    Richez, F.
    Tougeron-Brousseau, B.
    Genevois, O.
    Muraine, M.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2010, 33 (09): : 630 - 636
  • [4] Subconjunctival bevacizumab for corneal neovascularization
    Zaki, Ahmed A.
    Farid, Samar F.
    ACTA OPHTHALMOLOGICA, 2010, 88 (08) : 868 - 871
  • [5] Subconjunctival bevacizumab lnjection for corneal neovascularization
    Bahar, Irit
    Kaiserman, Igor
    McAllum, Penny
    Rootman, David
    Slomovic, Allan
    CORNEA, 2008, 27 (02) : 142 - 147
  • [6] Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
    Britton, Anna Krystyna
    Crayford, Basil Bamford
    CASE REPORTS IN OPHTHALMOLOGY, 2020, 11 (03): : 652 - 657
  • [7] The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization
    Eski, M. T.
    Teberik, Kuddusi
    Oltulu, Pembe
    Ankarali, Handan
    Kaya, Murat
    Alpay, Merve
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [8] The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization
    Eski, M. T.
    Teberik, Kuddusi
    Oltulu, Pembe
    Ankarali, Handan
    Kaya, Murat
    Alpay, Merve
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [9] Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model
    Papathanassiou, Miltiadis
    Theodossiadis, Panagiotis G.
    Liarakos, Vasilios S.
    Rouvas, Alexandros
    Giamarellos-Bourboulis, Evaggelos J.
    Vergados, Ioannis A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (03) : 424 - 431
  • [10] Subconjunctival and intrastromal Bevacizumab to control of corneal neovascularization and opacification
    Mendez, Silvia
    Santiago, Maria
    Raposo, Elena
    Tourino, Rosario
    Teresa Rodriguez-Ares, Maria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345